Discover our initiatives in various therapeutic areas
Lacosamide SPC® is indicated for the treatment of certain types of epilepsy in adults and children from 4 years of age.
50 mg
100 mg
150 mg
200 mg
Lacosamide
Dimethyl Fumarate SPC® is indicated for the treatment of adult patients with Relapsing remitting multiple sclerosis (RRMS).
120 mg
240 mg
Dimethyl Fumarate
Eligon® is indicated as a single disease modifying therapy in highly active relapsing remitting multiple sclerosis (RRMS)
0.5 mg
Fingolimod